Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04515836
Title Olaparib in Patients With HRD Malignant Mesothelioma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Chicago
Indications

malignant mesothelioma

Therapies

Olaparib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Chicago Medical Center Recruiting Chicago Illinois 60615 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field